Vladimir Kolesnichenko PhD

Vladimir Kolesnichenko PhD

Professor
  • Synthesis and     characterization of ultrasmall magnetic nanoparticles for biomedical     applications.
  • we are developing novel MRI imaging agents which be     selectively recognized by cancerous cells.  Their size and     amphiphilic properties will be optimized to avoid phagocytic and     early renal clearance, which will make them an effective tool for early     detection of cancer.  
  • National Taras Shevchenko University, Kyiv, Ukraine     (BS, MS); Institute of General and Inorganic Chemistry, Kyiv,     Ukraine (PhD); The University of Iowa (Postdoc)
  • ORCID: https://orcid.org/0000-0001-5497-7085
  • NCBI: https://www.ncbi.nlm.nih.gov/sites/myncbi/1hEVrJkxduZ5J/bibliography/48720938/public/?page=1
  • Selected publications: (a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces.  Rajesh Komati, Carl     Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir     Kolesnichenko, Chemistry-A European Journal, 2018, 24, 14824-14829.      (b) A Versatile Method of Ambient-Temperature Solvent Removal. Igor     Kolesnichenko, Galina Goloverda and Vladimir Kolesnichenko, Organic     Process Research & Development, 2020, 24, 25-31.
  • Keywords: superparamagnetic nanoparticles, MRI contrast agents

LCRC Faculty

Nakhle Saba MD
Translational Oncology
Our Lady of the Lake / LSU Health
Hana Safah, MD
Translational Oncology
Our Lady of the Lake / LSU Health
Maria Sanchez-Pino PhD
Cancer Biology
LSU Health - New Orleans
Dr. Oliver Sartor
Translational Oncology
Tulane University School of Medicine
Suzana Savkovic PhD
Cancer Biology
Tulane University School of Medicine
Tiffany N. Seagroves PhD
Cancer Biology
Tulane University School of Medicine
Qiang Shen MD PhD
Translational Oncology
LSU Health - New Orleans
Guillaume Spielmann, PhD
Genes X Environment
LSU A&M- Baton Rouge
Jayalakshmi Sridhar PhD
Translational Oncology
Xavier University